Company intelligence / Profile preview

Sirma Medical Systems

Ownership: Private
Development stage: Other

Overview

Sirma Medical Systems has developed and commercialized CE-certified Class I medical device software solutions for diabetes and chronic disease management. Their flagship product, Diabetes:M, has received multiple awards as a leading diabetes tracking app. The company holds ISO 13485 certification for quality control in medical devices. Clinical results are not directly applicable as the products are software tools/platforms rather than therapeutics.

Therapeutic areas: EndocrinologyOther
Modalities: DeviceNon-pharmacological therapyPlatform technology
Industry: Digital Health Medical Devices

Partnerships

Medical Centre Dr. Kalchev – license agreement to use Medrec:M Clinic platform in clinical practice.Digital Health and Innovations Cluster Bulgaria – full member since March 2023.

Beyond the preview

Go deeper on Sirma Medical Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sirma Medical Systems.

Explore the full profile